Quantitative measurement of microvascular permeability in human brain tumors achieved using dynamic contrast-enhanced MR imaging: Correlation with histologic grade

American Journal of Neuroradiology

Volumn 21, Issue 5, 2000, Pages 891-899

  Roberts, Heidi C ^a   Roberts, Timothy P L ^a   Brasch, Robert C ^a   Dillon, William P ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GADODIAMIDE;

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD VESSEL PERMEABILITY; BRAIN TUMOR; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; CORRELATION FUNCTION; DISEASE CLASSIFICATION; FEMALE; HISTOLOGY; HUMAN; HUMAN TISSUE; MALE; MEASUREMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; SCORING SYSTEM;

ADULT; AGED; BLOOD FLOW VELOCITY; BLOOD-BRAIN BARRIER; BRAIN NEOPLASMS; CONTRAST MEDIA; FEMALE; GADOLINIUM DTPA; GLIOMA; HUMANS; IMAGE ENHANCEMENT; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; MICROCIRCULATION; MIDDLE AGED; NEOPLASM STAGING; NEOVASCULARIZATION, PATHOLOGIC;

EID: 0034060928     PISSN: 01956108     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. Hirata A, Baluk P, Fujiwara T, McDonald DM. Location of focal silver staining at endothelial gaps in inflamed venules examined by scanning electron microscopy. Am J Physiol 1995;269: L403-418
2. Nugent LJ, Jain RK. Extravascular diffusion in normal and neoplastic tissues. Cancer Res 1984;44:238-244
3. Jain RK, Gerlowski LE. Extravascular transport in normal and tumor tissues. Crit Rev Oncol Hematol 1986;5:115-170
4. Jain RK. Vascular and interstitial barriers to delivery of therapeutic agents in tumors. Cancer Metastasis Rev 1990;9: 253-266
5. Brasch R. Pham C, Shames D, et al. Assessing tumor angiogenesis using macromolecular MR imaging contrast media. J Magn Reson Imaging 1997;7:68-74
6. Folkman J. The role of angiogenesis in tumor growth. Semin Cancer Biol 1992;3:65-71
7. van Dijke CF, Brasch RC, Roberts TP, et al. Mammary carcinoma model: correlation of macromolecular contrast-enhanced MR imaging characterizations of tumor microvasculature and histologic capillary density. Radiology 1996;198: 813-818
8. Schwickert HC, Stiskal M, Roberts TP, et al. Contrast-enhanced MR imaging assessment of tumor capillary permeability: effect of irradiation on delivery of chemotherapy. Radiology 1996;198:893-898
9. Gossmann A, Okuhata Y, Shames DM, et al. Prostate cancer tumor grade differentiation by dynamic contrast-enhanced MR imaging: comparison of macromolecular and small-molecular contrast media. Radiology (in press)
10. Daldrup H, Shames DM, Wendland M, et al. Correlation of dynamic contrast-enhanced MR imaging with histologic tumor grade: comparison of macromolecular and small-molecular contrast media. AJR Am J Roentgenol 1998;171:941-949
11. Pham CD, Roberts TP, van Bruggen N, et al. Magnetic resonance imaging detects suppression of tumor vascular permeability after administration of antibody to vascular endothelial growth factor. Cancer Invest 1998;16:225-230
12. Gossmann A, Ostrowitzki S, Helbich T, et al. Effects of anti-VEGF antibody on malignant gliomas assessed by dynamic contrast enhanced MRI. In: Proceedings of International Society of Magnetic Resonance in Medicine: Sydney, Australia, 1998. International Society of Magnetic Resonance in Medicine; 1998:370
13. Schwickert HC, Roberts TP, Shames DM, et al. Quantification of liver blood volume: comparison of ultra short T1 inversion recovery echo planar imaging (ULSTIR-EPI), with dynamic 3D-gradient recalled echo imaging. Magn Reson Med 1995;34: 845-852
14. Roberts TP. Physiologic measurements by contrast-enhanced MR imaging: expectations and limitations. J Magn Reson Imaging 1997;7:82-90
15. Hittmair K, Gomiscek G, Langenberger K, Recht M, Imhof H, Kramer J. Method for the quantitative assessment of contrast agent uptake in dynamic contrast-enhanced MRI. Magn Reson Med 1994;31:567-571
16. Tofts PS. Modeling tracer kinetics in dynamic Gd-DTPA MR imaging. J Magn Reson Imaging 1997;7:91-101
17. Tofts PS, Kermode AG. Measurement of the blood-brain barrier permeability and leakage space using dynamic MR imaging, 1: fundamental concepts. Magn Reson Med 1991;17: 357-367
18. Shames DM, Kuwatsuru R, Vexler V, Mühler A, Brasch RC. Measurement of capillary permeability to macromolecules by dynamic magnetic resonance imaging: a quantitative noninvasive technique. Magn Reson Med 1993;29:616-622
19. Patlak CS, Goldstein DA, Hoffman JF. The flow of solute and solvent across a two-membrane system. J Theor Biol 1963;5: 426-442
20. Patlak CS, Blasberg RG, Fenstermacher JD. Graphic evaluation of blood-to-brain transfer constants from multiple-time uptake data. J Cereb Blood Flow Metab 1983;3:1-7
21. Demsar F, Roberts TP, Schwickert HC, et al. A MRI spatial mapping technique for microvascular permeability and tissue blood volume based on macromolecular contrast agent distribution. Magn Reson Med 1997;37:236-242
22. Aronen HJ, Glass J, Pardo FS, et al. Echo-planar MR cerebral blood volume mapping of gliomas: clinical utility. Acta Radiol 1995;36:520-528
23. Rosen BR, Belliveau JW, Aronen HJ. et al. Susceptibility contrast imaging of cerebral blood volume: human experience. Magn Reson Med 1991;22:293-299
24. Maeda M, Itoh S, Kimura H, et al. Tumor vascularity in the brain: evaluation with dynamic susceptibility-contrast MR imaging. Radiology 1993;189:233-238
25. Lammertsma A, Wise R, Jones T. In vivo measurements of regional cerebral blood flow and blood volume in patients with brain tumours using positron emission tomography. Acta Neurochir 1983;69:5-13
26. Black K, Emerick T, Hoh C, Hawkins R, Mazziotta J, Becker D. Thallium-201 SPECT and positron emission tomography equal predictors of glioma grade and recurrence. Neurol Res 1994;16:93-96
27. 18F-fluorodeoxyglucose PET. AJR Am J Roentgenol 1994;163:1459-1465
28. Kaplan WD, Takvorian T, Morris JH, Rumbaugh CL, Connolly BT, Atkins HL. Thallium-201 brain tumor imaging: a comparative study with pathologic correlation. J Nucl Med 1987;28: 47-52
29. Kim KT, Black KL, Marciano D, et al. Thallium-201 SPECT imaging of brain tumors: methods and results. J Nucl Med 1990;31:965-969
30. Vertosick FT, Selker RG, Grossman SJ, Joyce JM. Correlation of thallium-201 single photon emission computed tomography and survival after treatment failure in patients with glioblastoma multiforme. Neurosurgery 1994;1994:396-401
31. Siegal T, Rubinstein R, Tzuk-Shina T, Gomori JM. Utility of relative cerebral blood volume mapping derived from perfusion magnetic resonance imaging in the routine follow up of brain tumors. J Neurosurg 1997;86:22-27
32. Villringer A, Rosen BR, Belliveau JW, et al. Dynamic imaging with lanthanide chelates in normal brain: contrast due to magnetic susceptibility effects. Magn Reson Med 1988;6:164-174
33. Rosen BR, Belliveau JW, Aronen H. et al. Susceptibility contrast imaging of cerebral blood volume: human experience. Magn Reson Med 1991;22:293-299
34. Kucharczyk J, Roberts T, Moseley ME, Watson A. Contrast-enhanced perfusion-sensitive MR imaging in the diagnosis of cerebrovascular disorders. J Magn Reson Imaging 1993;3: 241-245
35. Kucharczyk J, Vexler ZS, Roberts TP. et al. Echo-planar perfusion-sensitive MR imaging of acute cerebral ischemia. Radiology 1993;188:711-717
36. Perman WH, Gado MH, Larson KB, Perlmutter JS. Simultaneous MR acquisition of arterial and brain signal-time curves. Magn Reson Med 1992;28:74-83
37. Ostergaard L, Sorensen AG, Kwong KK, Weisskoff RM, Gyldensted C, Rosen BR. High resolution measurement of cerebral blood flow using intravascular tracer bolus passages, II: experimental comparison and preliminary results. Magn Reson Med 1996;36:726-736
38. Ostergaard L, Weisskoff RM, Chesler DA, Gyldensted C, Rosen BR. High resolution measurement of cerebral blood flow using intravascular tracer bolus passages, I: mathematical approach and statistical analysis. Magn Reson Med 1996;36:715-725
39. Hackländer T, Reichenbach JR, Mödder U. Comparison of cerebral blood volume measurements using the T1 and T2 * methods in normal human brains and brain tumors. J Comput Assist Tomogr 1997;21:857-866
40. Hackländer T, Hofer M, Reichenbach JR, Rascher K, Fürst G, Mödder U. Cerebral blood volume maps with dynamic contrast-enhanced T1-weighted FLASH imaging: normal values and preliminary clinical results. J Comput Assist Tomogr 1996; 20:532-539
41. Petrella JR, Wong J, Provenzale JM. False positive cerebral blood volume maps: a potential pitfall in evaluation of monoclonal antibody-treated gliomas. In: Proceedings of Joint Meeting of the ASNR, ASHNR, ASPNR, ASITN, ASSR: Sun Diego, CA, 1990. Oak Brook, IL: American Society of Neuroradiology; 1999:59
42. Roberts HC, Saeed M, Roberts TP, et al. Comparison of albumin-(Gd-DTPA)30 and Gd-DTPA-24-cascade-polymer for measurements of normal and abnormal microvascular permeability. J Magn Reson Imaging 1997;7:331-338
43. Brix G, Semmler W, Port R, Schad L, Layer G, Lorenz W. Pharmacokinetic parameters in CNS Gd-DTPA enhanced MR imaging. J Comput Assist Tomogr 1991;15:621-628
44. Su MY, Najafi AA, Nalcioglu O. Regional comparison of tumor vascularity and permeability parameters measured by albumin-Gd-DTPA and Gd-DTPA. Magn Reson Med 1995;34: 402-411
45. Tofts PS, Berkowitz B, Schnall MD. Quantitative analysis of dynamic Gd-DTPA enhancement in breast tumors using a permeability model. Magn Reson Med 1995;33:564-568
46. Wong ET, Jackson EF, Hess KR. et al. Correlation between dynamic MRI and outcome in patients with malignant gliomas. Neurology 1998;50:777-781
47. Russel D, Rubinstein L. Tumors of central neuroepithelial origin. In: Pathology of Tumours of the Nervous System. Baltimore: Williams & Wilkins: 1989;83
48. Sugahara T, Korogi Y, Kochi M, et al. Correlation of MR imaging-determined cerebral blood volume maps with histologic and angiographic determination of vascularity of gliomas. AJR Am J Roentgenol 1998;171:1479-1486